Vitalhub (TSE:VHI) has released an update.
VitalHub Corp. has reported a robust financial performance for the second quarter of 2024, with a 24% increase in total revenue and a significant 41% rise in adjusted EBITDA. The company’s strong results are underpinned by a 25% growth in annual recurring revenue and an 86% surge in net income before taxes, reflecting solid organic growth, operational excellence, and strategic acquisitions like MedCurrent Corporation.
For further insights into TSE:VHI stock, check out TipRanks’ Stock Analysis page.
